Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration by Howe, A. K. et al.
Spatial regulation of the cAMP-dependent protein
kinase during chemotactic cell migration
Alan K. Howe*†, Linda C. Baldor*, and Brian P. Hogan‡
*Department of Pharmacology and the Vermont Cancer Center, The University of Vermont, 149 Beaumont Avenue, HSRF 322, Burlington, VT 05405-0075;
and ‡Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599
Communicated by Susan S. Taylor, University of California at San Diego, La Jolla, CA, August 15, 2005 (received for review November 3, 2004)
Historically, the cAMP-dependent protein kinase (PKA) has a par-
adoxical role in cell motility, having been shown to both facilitate
and inhibit actin cytoskeletal dynamics and cell migration. In an
effort to understand this dichotomy, we show here that PKA is
regulated in subcellular space during cell migration. Immunofluo-
rescence microscopy and biochemical enrichment of pseudopodia
showed that type II regulatory subunits of PKA and PKA activity are
enriched in protrusive cellular structures formed during chemo-
taxis. This enrichment correlates with increased phosphorylation
of key cytoskeletal substrates for PKA, including the vasodilator-
stimulated phosphoprotein (VASP) and the protein tyrosine phos-
phatase containing a PEST motif. Importantly, inhibition of PKA
activity or its ability to interact with A kinase anchoring proteins
inhibited the activity of the Rac GTPase within pseudopodia. This
effect correlated with both decreased guanine nucleotide ex-
change factor activity and increased GTPase activating protein
activity. Finally, inhibition of PKA anchoring, like inhibition of total
PKA activity, inhibited pseudopod formation and chemotactic cell
migration. These data demonstrate that spatial regulation of PKA
via anchoring is an important facet of normal chemotactic cell
movement.
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Defining the biochemical mechanisms that control cell mi-gration directly contributes to our understanding of phys-
iologic events in which migration is normally required (e.g.,
embryonic development, wound healing, and angiogenesis) and
those in which it is subverted for pathogenesis (e.g., cancer
metastasis) (1). In vivo, the regulation of cell migration is
achieved through a complex network of signals arising from cell
surface receptors for extracellular matrix, other cells, and soluble
factors such as peptide growth factors and bioactive lipids (2).
Gradients of these extracellular ligands establish a gradient of
engaged receptors on the cell surface that directs localized
polymerization of actin and formation of protrusive leading edge
structures, such as lamellipodia and filopodia, in the direction of
eventual cell migration. Recent evidence indicates that estab-
lishing and maintaining cell polarity during migration depends
on not only the bulk activity or abundance of cellular compo-
nents that preside over cytoskeletal dynamics, but also the strict
regulation of their activity or abundance in subcellular space
(3, 4).
The cAMP-dependent protein kinase (PKA) is extremely
promiscuous with its activity (5), with targets in the plasma
membrane, cytoplasm, mitochondria, nucleus, and nearly every
family of cytoskeletal network, including microtubules, interme-
diate filaments, and actin microfilaments (5, 6). Historically,
PKA plays a dichotomous role in actin cytoskeletal organization
and cell migration, exerting both negative (i.e., inhibitory) and
positive (i.e., required or enhancing) effects (reviewed exten-
sively in ref. 6). PKA can be both positively and negatively
regulated by cell adhesion and during cell spreading (7–10).
Furthermore, although some hallmarks of cell migration and
cytoskeletal assembly require PKA activity [e.g., activation of
Rac (9, 11), Cdc42 (12), and microfilament assembly (10)],
others are inhibited by it [e.g., activation of Rho (13) and
p21-activated kinase (7), interaction between vasodilator-
stimulated phosphoprotein (VASP), and the c-Abl tyrosine
kinase (8), actin polymerization (14)]. Finally, cell migration and
invasion have been shown to either require PKA activity (9,
15–17) or be inhibited by it (15, 16, 18, 19). A prototypical
example of the dichotomous nature of PKA regulation of cell
migration is the data showing that v3 integrin-dependent
endothelial cell migration is both positively (11) and negatively
(18) regulated by PKA. These ostensibly disparate observations
indicate that PKA can both inhibit and facilitate cell migration
and suggest a significant degree of complexity for regulation of
PKA activity during migration.
These positive and negative effects and the number and variety
of putative targets through which they might be elicited (6)
suggest that there must be a mechanism in place for specifying
or focusing PKA activity during cell migration to properly and
accurately assign its functions. One hypothesis is that PKA
activity might be spatially regulated during cell migration, and,
thus, arrant activation or inhibition of PKA would disrupt the
spatial specificity of its activity and hamper overall migration.
The case for spatial regulation of PKA is strong, because a vast
and growing literature indicates that recruitment or enrichment
of PKA to specific subcellular regions or structures, through
interaction with A kinase anchoring proteins (AKAPs), facili-
tates PKA-dependent signaling in those regions and is likely
required for determining the specificity of the PKA signaling
(20). Because of the abundant literature describing AKAP-
mediated anchoring of PKA to membranous and cytoskeletal
regions (20, 21), we investigated the hypothesis that PKA may be
spatially regulated during cell migration. Here, we show that a
subset of PKA holoenzyme, as well as PKA activity and phos-
phorylated substrates, are enriched in protrusive, leading-edge
structures formed during chemotactic cell movement. Moreover,
inhibition of PKA activity or AKAP-mediated localization pre-
vents directed cell migration.
Experimental Methods
Antibodies and Other Reagents. Detailed descriptions of antibodies
and sundry materials can be found in the Supporting Text, which
is published as supporting information on the PNAS web site, or
can be requested from the corresponding author.
Immunofluorescence. Serum-starved cells were detached and re-
plated (8) on coverslips coated with 10 gml fibronectin. After
incubation and treatment as described in the figure legends, cells
were fixed in PBS3.7% formaldehyde for 10 min, permeabilized
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in PBS0.5% Triton X-100 for 5 min, blocked in PBS2% BSA,
stained with primary antibodies, phalloidin, Alexa-conjugated
secondary antibodies, andor DAPI (all diluted in block), then
mounted on slides by using PermaFluor (Thermo Shandon,
Pittsburgh). Cells were visualized through 40 or 60 PlanApo
objectives on Olympus IX70 microscopes equipped for epif lu-
orescence (with an F-View II charge-coupled device camera
controlled by ANALYSIS software (Soft Imaging Systems) or
confocal microscopy (FluoView 300 system and software).
Pseudopod Preparation and Quantification. These techniques were
performed as described in ref. 22. Briefly, cells were replated for
2 h on fibronectin-coated, 3 m-pore polycarbonate membranes
in Costar Transwell inserts. Where indicated, pharmacological
agents at the indicated concentrations were added to both
chambers for 20 min, then chemoattractant was added to the
lower chamber for 1 h. For pseudopod quantification or harvest,
inserts were washed in PBS, cell bodies (CBs) were removed
from the upper surface, and the pseudopodia (Pd) on the
underside were scraped into lysis buffer. Alternatively, Pd were
removed, and CB on the upper surface were harvested. Lysates
were clarified by centrifugation and protein content quantified
by bicinchoninic acid assay (Pierce).
Cell Migration Studies. Cells were cultured as for pseudopod
preparations but by using 8-m-pore Transwell inserts. Cultures
were incubated at 37°C for 8 h, then nonmigrating cells were
removed from the top chamber with cotton swabs and the
remaining cells were fixed for 10 min in 3.7% formaldehyde
0.5% Triton X-100 in PBS, stained with DAPI, mounted, and
counted by fluorescence microscopy.
Western Blotting, Immunoprecipitation, Transfections, and PKA Ac-
tivity Assays. These techniques were performed as described in
refs. 7 and 8. VASP tagged with an epitope from a vesicular
stomatitis virus protein was expressed under control of the
cytomegalovirus promoter as described in ref. 8.
Phosphatase, Rac, GTPase Activating Protein (GAP), and Guanine
Nucleotide Exchange Factor (GEF) Activity Assays. The activity of
immunoprecipitated protein tyrosine phosphatase containing a
PEST motif (PTP-PEST) was assessed by using an in vitro
phosphatase assay according to the manufacturer’s instructions
(Promega). Activation of Rac was determined with a pulldown
assay by using a GST fusion with the p21-binding domain of
p21-activated kinase as described in refs. 22 and 23. GAP and
GEF assays were performed essentially as described in ref. 24.
GST-Rac1 (1 g) was incubated with 20 Ci (1 Ci  37 GBq)
of -32P-GTP (for GAP assays) or -32P-GTP (for GEF assays)
in nucleotide loading buffer (25 mM Tris, pH 7.550 mM NaCl5
mM EDTA1 mg/ml BSA0.1 mM DTT) for 20 min at 25°C.
MgCl2 was added to 25 mM, and the mixture was kept on ice until
use. Pd were harvested in lysis buffer (see ref. 24 and Supporting
Text), cleared by centrifugation, and 250 g was mixed with
nucleotide-loaded Rac in the presence of 1 mM GTP and
incubated at 20°C. Fifty-microliter aliquots were removed at the
indicated times and filtered through nitrocellulose. Filters were
washed extensively with wash buffer (loading buffer with 20 mM
MgCl2 instead of EDTA) and bound radioactivity quantified by
scintillation counting.
Results
Type-II PKA Regulatory Subunit Localizes to Protrusive Structures
During Migration. Both inhibition and hyperactivation of PKA
appear to have deleterious effects on chemotactic cell migration
(reviewed extensively in ref. 6 and demonstrated in Fig. 6, which
is published as supporting information on the PNAS web site).
These disparate observations suggest that PKA activity is indeed
required for successful chemotaxis, but in a tightly regulated
manner, and that arrant activation or inhibition perturbs this
regulation and impedes migration. To investigate whether the
role of PKA in cell migration might involve spatial regulation of
the kinase, we examined the localization of PKA subunits in
migrating cells by immunofluorescence microscopy. We focused
our efforts on the  isoform of the PKA type II regulatory
subunit (RII), as AKAP-mediated localization of PKA occurs
most frequently through type II, rather than type I, subunits (20).
PKA RII was enriched in protrusive cellular structures formed
in response to platelet-derived growth factor (PDGF) or lyso-
phosphatidic acid (LPA) (Fig. 1A). Although previous work
demonstrated localization of RII to actin-rich dorsal ruffles
induced by PDGF (25), the current data demonstrate a polarized
enrichment of RII within putative leading edge structures. This
enrichment suggests that the function of PKA during cell mi-
gration might be modulated, in part, by localization of PKA RII
to protrusive, lamellipodial structures formed during
chemotaxis.
PKA Subunits and Activity are Enriched in Pd. To further explore
localization of PKA during chemotaxis, we adapted a recently
described, elegant subcellular fractionation technique that en-
riches for the growing Pd formed by migrating cells (22). In this
technique, cells plated on one side of a thin, porous polymer
filter coated with fibronectin are stimulated to migrate toward a
chemoattractant on the opposite side and, thus, send one or
more Pd through the filter pores (Fig. 1B). The filter provides a
physical divider between the CB and Pd and, thus, allows
separation and biochemical analysis of each fraction.
Equal amounts of CB and Pd protein were analyzed by
Western blotting with antibodies against various PKA subunits.
In agreement with immunofluorescence data, the relative level
of PKA RII was greater in the Pd than in the CB (Fig. 1 C and
D). The localization of the PKA regulatory subunit type I was
more variable and cell type-specific, showing slight enrichment
in the CB of REF52 (Fig. 1C) and WI38 fibroblasts (data not
shown), but a slight (50%) enrichment in Pd of NIH 3T3
fibroblasts (Fig. 1C) and a greater enrichment in A7r5 smooth
muscle cells and some epithelial cell lines (data not shown).
Interestingly, although there was no obvious enrichment of PKA
catalytic subunit (PKA-C) in either subcellular compartment in
REF52 cells (Fig. 1D) or in NIH 3T3 cells (data not shown),
actual PKA activity in Pd was significantly higher than in CB
(Fig. 1E). Thus, the enrichment of PKA RII in lamellipodiaPd
observed by immunofluorescence and immunoblotting corre-
lates with increased PKA activity in these protrusive structures.
The increased activity of PKA in Pd suggests that the level of
phosphorylation of PKA substrates might be higher in Pd than
in CB. Indeed, exploratory analyses of CB and Pd fractions,
separated by one- and two-dimensional electrophoresis, by stain-
ing with a phosphoprotein-specific stain (ProQ Diamond, In-
vitrogen) or by immunoblotting with a phospho-PKA-substrate
antibody, showed a large number of reactive bands or spots
present in Pd and not in CB (data not shown). To explore this
increased phosphorylation in a more specific manner, we exam-
ined the phosphorylation state of two recently described PKA
targets with particular relevance to cytoskeletal regulation and
cell migration.
VASP Phosphorylation Is Enriched and VASP–Abl Interaction Is Dis-
rupted in Pd. VASP is the founding member of a family of proteins
with increasingly prominent and complex roles in actin cytoskel-
etal dynamics and cell migration (26). All mammalian VASP
proteins are substrates for PKA (27), and phosphorylation has
been shown to be crucial for regulating their function (26),
particularly their role in regulating cell migration (28, 29). We
therefore analyzed the relative phosphorylation of VASP in Pd








and CB. Phosphospecific antibody reactivity and electrophoretic
mobility shift both showed that VASP phosphorylation was
significantly higher in Pd than in CB (Fig. 2 A and B), consistent
with the increased level of PKA activity in Pd.
An immediate consequence of PKA-mediated VASP phos-
phorylation is inhibition of VASP interaction with the c-Abl
tyrosine kinase (8). We therefore investigated whether parti-
tioning of PKA activity and VASP phosphorylation correlated
with a spatial regulation of VASP–Abl interaction in migrating
cells. To compensate for the small amount of protein harvested
from Pd (22) and the requirement for a relatively large amount
of material to observe VASP–Abl interaction (8), we used COS-7
cells transfected with an epitope-tagged version of wild-type
VASP and prepared anti-epitope immunoprecipitates from Pd
and CB extracts. As expected, coprecipitation of c-Abl with
VASP was much lower in Pd than in CB (Fig. 2C), consistent
with increased level of phosphorylated VASP in this fraction
(Fig. 2 A and B).
PKA Phosphorylation of PTP-PEST is Enriched in Pd. PTP-PEST, a
protein tyrosine phosphatase and an increasingly important
regulator of cell migration (30, 31), can be directly phosphor-
ylated and inhibited by PKA (32). To assess whether localiza-
tion of PKA activity correlated with spatial regulation of
PTP-PEST phosphorylation, we immunoprecipitated PTP-
PEST from CB and Pd extracts and immunoblotted the
precipitates with an antibody specific for PKA-phosphorylated
substrates. Although phosphorylation of PTP-PEST was
barely detectable in stably adherent but nonmotile cells on
tissue culture plates, induction of chemotaxis resulted in
PKA-mediated phosphorylation PTP-PEST specifically in Pd
(Fig. 3A).
The enrichment of PKA activity within Pd suggested that
blocking PKA activity or anchoring within these structures
should affect substrate phosphorylation. To test this hypothesis,
cell-permeable peptides from the PKA inhibitor protein (myr-
istoylated PKI peptide; mPKI) or the AKAP Ht31 (stearated
Ht31 peptide; StHt31) were used to inhibit PKA activity or
anchoring, respectively. Specifically, Pd were allowed to form as
described, then PKA activity or anchoring was locally inhibited
within these structures by the addition of inhibitors to the
underside of the filter. Surprisingly, inhibition of neither PKA
activity nor anchoring had any significant effect on the phos-
phorylation of VASP within Pd (Fig. 7, which is published as
supporting information on the PNAS web site), but both inter-
ventions significantly inhibited the phosphorylation of PTP-
PEST (Fig. 4B). As phosphorylation by PKA inhibits PTP-PEST,
decreased phosphorylation should correlate with increased
phosphatase activity. To test this hypothesis, phosphatase assays
were performed on PTP-PEST immunoprecipitated from
PDGF-stimulated Pd that were left untreated, or treated with
mPKI or StHt31. As expected, inhibition of PKA activity or
anchoring within Pd resulted in a significant increase in PTP-
PEST activity (Fig. 4C). The importance of this effect is under-
scored by the observation that inhibition of PKA activity or
anchoring dramatically inhibited the migration-induced tyrosine
phosphorylation of p130Cas, a key PTP-PEST substrate (33) and
important regulator of cell migration (34) (Fig. 8, which is
published as supporting information on the PNAS web site).
These data show that localized PKA activity regulates PTP-
PEST activity during Pd formation.
An important potential downstream target for PKA-mediated
regulation of PTP-PEST is the Rac GTPase, a sine qua non
regulator of lamellipodia formation and cell migration whose
activity has been shown to localize to the leading edge (35) and
Pd (22), require PKA (9), and be downstream of both PTP-PEST
and p130Cas (22, 31). To investigate the contribution of PKA
activity and anchoring to localized regulation of Rac, Rac
Fig. 1. PKA subunits and activity are enriched in Pd. (A) REF52 or WI38 fibroblasts were plated onto fibronectin-coated coverslips for 90 min, then stimulated
for 1 h with 10 ngml PDGF (REF52) (Top and Middle) or 100 ngml LPA (WI38) (Bottom). Cells were fixed and processed for immunofluorescence by using
antibodies against the indicated proteins and fluorescent phalloidin to stain F-actin as indicated, then examined by confocal microscopy. (Middle) Enlargements
are shown of the area indicated by the square in Upper Left. (Scale bar: 10 m.) (B) REF52 cells were cultured for pseudopod formation as described in
Experimental Methods, then fixed, stained with Alexa 488-phalloidin, and imaged by confocal microscopy. (Left) The diagram shows the preparation and orients
the reader to Center, which shows a 3D reconstruction of a single cell prepared and imaged as described. The top of the cell appears flat because the image stack
stops approximately halfway through the cell nucleus. (Right) The same cell is shown, rotated upward 30o about the horizontal axis to illustrate the Pd’s fine
structure. Movie 1, which is published as supporting information on the PNAS web site, shows a 180° rotation of this image. (C and D) Twenty micrograms of
protein prepared from CB from unstimulated cells (Un), or from CB and Pd formed in response to PDGF, EGF, and PDGF (10 ngml each; EP), or LPA, were
immunoblotted with the indicated antibodies. (E) PKA activity was determined from equal amounts of protein prepared from unstimulated (Ctrl) REF52 cells
or CB (open bars) and Pd (filled bars) formed in response to LPA or PDGF. Data (as cpm per g of lysate) represent means  SD for three independent Pd
preparations processed simultaneously for kinase activity.
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activity was assayed from CB and Pd extracts in the absence or
presence of mPKI or StHt31. As reported in ref. 22, activation
of Rac was almost entirely relegated to the Pd fraction (Fig. 4 A
and B). Importantly, Rac activity within Pd was significantly
inhibited by inhibition of either PKA activity or anchoring (Fig.
4 A and B).
Inhibition of Rac activity may be due to decreased activity of
Rac-specific GEFs or increased activity of Rac-specific GAPs.
To investigate these possibilities, GEF and GAP activities in
control-, mPKI-, and StHt31-treated Pd were measured by using
recombinant Rac. Interestingly, inhibition of PKA activity or
anchoring resulted in both decreased Rac-GEF and increased
Rac-GAP activities (Fig. 4 C and D). These critically important
data show that localized PKA activity can preside over Rac, a
crucial regulator of leading edge events and cell migration,
through modulation of GEF and GAP activities.
PKA Activity and Anchoring Are Required for Pseudopod Stability,
Formation, and Chemotaxis. The dramatic effect of the mPKI and
StHt31 peptides on Rac activity, along with the published
observation that Rac activity is greatly diminished in retracting
Pd (22), suggested that inhibition of PKA activity or anchoring
might result in Pd destabilization and retraction. Indeed, anec-
dotal evidence from optimizing conditions for the experiments
in Figs. 3 B and C and 4 suggested that prolonged incubation with
inhibitors severely diminished the amount of Pd protein recov-
ered. To formally test this hypothesis, Pd were induced then
treated with mPKI or StHt31 for increasing periods of time
before quantification. The amount of Pd material did indeed
Fig. 2. Localized PKA activity correlates with enrichment of PKA-
phosphorylated VASP. (A) REF52 CB and Pd, formed in response to PDGF, EGF,
or LPA, were blotted for PKA-phosphorylated VASP (pVASP; p157-VASP) or
the retinoblastoma protein (Rb), which resides in the nucleus and is therefore
present only in CB. (B) CB from unstimulated NIH 3T3 cells (Un), or CB and Pd
formed in response to PDGF or EGF, were blotted with an antibody against
VASP. (C) COS7 cells transfected with epitope-tagged VASP (VSV-VASP) were
either treated with 25 M Fsk for 20 min or cultured for EGF-induced pseu-
dopod formation. Lysates from Fsk-treated cells (Fsk) and from CB and Pd were
immunoprecipitated with antivesicular stomatitis virus antibody. Precipitates
and whole cell extract (wce) from transfected cells were separated by SDS
PAGE and blotted with the indicated antibodies. A low-percentage gel was
used to collapse the phosphorylation-sensitive electrophoretic profile of VASP
(evident in B) to a single band for easier confirmation of equal loading.
Immunoblotting unprecipitated CB and Pd lysates with anti-Abl antibodies
confirmed the presence of c-Abl in both fractions (Lower).
Fig. 3. Localized regulation of PTP-PEST by PKA. (A and B) PTP-PEST was
immunoprecipitated from extracts of REF52 cells stably adherent to tissue
culture plastic (TC), CB, and Pd formed in response to PDGF, or Pd treated with
mPKI or StHt31 (as described in Fig. 2), then separated by SDSPAGE and
blotted with anti-PTP-PEST and anti-phospho-PKA substrate (p-PKA sub) an-
tibodies. (C) PTP-PEST was immunoprecipitated from PDGF-stimulated Pd
(Ctrl), or Pd treated with mPKI or StHt31 as described above, and subjected to
an in vitro phosphatase assay (see Experimental Methods) in which absor-
bance at 630 nm is proportional to released phosphate and, thus, phosphatase
activity. Data represent means  SD for three independent Pd preparations
immunoprecipitated and processed simultaneously for phosphatase activity.
Fig. 4. PKA activity controls Rac by regulating Rac GEF and Rac GAP activities
within Pd. (A and B) NIH 3T3 cells were cultured as in Fig. 2 D and E and CB and
Pd extracts were subject to a pulldown assay by using a GST-p21-binding
domain fusion protein to isolate the active form of Rac. A portion of the
extracts were collected before pulldown and immunoblotted directly to de-
termine total Rac levels. The bar graphs depict the average ratios of active to
total Rac,  SD, determined from three separate experiments by densitometry
of the immunoblotted bands. (C and D) Control- or inhibitor-treated Pd from
PDGF-stimulated NIH 3T3 cells were harvested and incubated with purified,
recombinant GST-Rac1 loaded with -32P-GTP (C) or -32P-GTP (D) for the
indicated times to measure Rac GEF or GAP activity, respectively. The data are
presented as the percent of radioactivity remaining bound to Rac1 in the
absence of extract and represent means  SD for four independent Pd
preparations processed simultaneously for GEF or GAP activity. Note that the
y axis in C does not go to zero.








diminish over time in the presence of mPKI or StHt31 (Fig. 5A),
indicating that prolonged inhibition of either PKA activity or
anchoring leads to destabilization andor retraction of Pd.
The data to this point suggested that both PKA activity and
anchoring might be required for chemotaxis. To test this hy-
pothesis, we first determined the effect of inhibition of PKA
activity or anchoring on Pd formation. Treatment of cells with
either StHt31 or mPKI before growth factor stimulation inhib-
ited Pd formation in a dose-dependent fashion and, to an extent,
comparable with total disruption of the actin cytoskeleton with
cytochalasin D (Fig. 5B). Pd formation was unaffected by
treatment with a control peptide incapable of disrupting PKA–
AKAP interaction (StHt31P) but was ablated by arrant activa-
tion of PKA with forskolin (Fsk) (Fig. 5B). Moreover, specific
inhibition of PKA anchoring, like inhibition of PKA activity, also
inhibited chemotactic cell migration in a dose-dependent man-
ner (Fig. 5C). These data show that successful chemotactic cell
migration requires not only PKA activity but also localization of
that activity through interaction with AKAPs.
Discussion
Chemotactic migration is a fundamentally important cellular
behavior. PKA has long been shown to exert both negative and
positive effects on cytoskeletal dynamics and cell migration.
However, little work has been done to reconcile these disparate
observations and carefully elucidate the contribution of this
venerable and ubiquitous kinase to the regulation of cell migra-
tion. Because the consequences of PKA activity are many and
because the targets for PKA activity are scattered far and wide
about the cellular landscape, the need for focusing or specifying
PKA activity is ostensibly greater, although perhaps less obvious,
than for proteins dedicated to a single purpose. The current data
reconcile prior observations by showing that PKA is spatially
regulated during cell migration and demonstrate the require-
ment of PKA anchoring for mammalian somatic cell migration.
It is important to note, however, that although the current data
implicate that localization of PKA within leading edge structures
is important for Pd formation and cell migration, they do no not
formally obviate potential roles for PKA anchored elsewhere to
preside over other processes related to cell migration (e.g., tail
retraction).
Given the significant enrichment in PKA activity within Pd,
the observed lack of enrichment of PKA-C in Pd may seem
curious. However, the currency of PKA activity is carried by the
amount of free (i.e., unbound to an R subunit) C subunit, rather
than its total amount. Thus, the bulk distribution of catalytic
subunit per se is not a faithful indicator of the distribution of PKA
activity, and this stresses the importance for subcellular andor
spatial analysis of PKA function. Indeed, this idea is a logical
extension of the concept that PKA signaling can be spatially
regulated through interaction with AKAPs and is one of the
central tenets of the current work. Compensatory enrichment of
RI subunits in the CB in some cell types (this study) and the
potential for excess R over C subunits (36) may also contribute
to this disparity.
VASP and its related proteins are increasingly important
regulators of actin dynamics during cell migration, and their
phosphorylation has been shown to be critical for regulating
their function in this regard (26–29). One consequence of
VASP phosphorylation is regulation of its interaction with
c-Abl, a nonreceptor tyrosine kinase closely linked to regula-
tion of cytoskeletal dynamics and cell migration in several
systems (37). Our data show that VASP–Abl interaction is
specifically disrupted within protrusive structures formed dur-
ing cell migration. It should be noted, however, that unlike Ena
(the Drosophila ortholog of VASP) and N-Mena (its mamma-
lian neuron-specific counterpart), VASP is not phosphory-
lated by Abl (26). Indeed, the biochemical consequences of
VASP–Abl interaction for the function of either protein are
currently unknown. Nonetheless, the importance of VASP and
Abl proteins in cell migration, the dynamic regulation of their
binding during cell spreading (8), and the current data all
support continued investigation of the role of this interaction
in cytoskeletal regulation.
The lack of effect of PKA inhibition on VASP phosphoryla-
tion within Pd is somewhat surprising. However, despite its
proven importance, the details of regulation of VASP phosphor-
ylation are still largely unknown. The existence of a VASP
phosphatase(s) has been directly implicated by pharmacological
studies (38) and may be inferred from the rapid dephosphory-
lation of VASP upon cell adhesion (8). Thus, one hypothesis is
that under the current culture conditions, the phosphorylation
and dephosphorylation of VASP may not be in rapid equilib-
rium. Thus, inhibition of PKA, in the absence of specific
activation of a putative phosphatase(s), does not result in
demonstrable dephosphorylation. Nonetheless, the importance
of VASP proteins, and their phosphorylation, in cell migration
suggest that regulation of VASP phosphorylation will still prove
to be an important function of localized PKA activity.
Unlike phosphorylation of VASP, PTP-PEST phosphoryla-
tion and activity as well as the activity of Rac within Pd were
significantly affected by localized disruption of PKA function.
Indeed, our data make an important connection between pre-
vious reports demonstrating a requirement of PKA activity for
activation of Rac (9, 11) and the localization of Rac activity to
leading-edge structures (35). Our demonstration that regulation
Fig. 5. PKA activity and anchoring are required for pseudopod stability and
formation and for chemotaxis. (A) REF52 cells were cultured for Pd formation
toward PDGF for 1 h. PBS (Ctrl), 20 M mPKI, or 50 M StHt31 was added to
the filter undersides and, at the indicated times, pseudopod formation was
quantified by measuring the amount of pseudopod protein by using a bicin-
choninic acid assay. Note that the y axis does not go to zero. (B and C) REF52
cells were cultured for Pd formation (B) or migration (C) by adding the
indicated concentrations of StHt31, StHt31P, mPKI, cytochalasin D, or Fsk (in
M) to the cells 20 min before addition of growth factor. Pd formation was
measured as above, whereas cell migration was measured as described in
Experimental Methods. Similar results were seen by using NIH 3T3 cells (data
not shown).
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of Rac by PKA ostensibly occurs through modulation of both
GEF and GAP function is made more intriguing by two recent
reports. First, PKA has been shown to directly phosphorylate the
RacCdc42 GEF PIX and, thus, regulate its translocation and
activation (39). Second, a complex comprising the 4 integrin,
paxillin, and Arf-GAP appears to be responsible for restricting
Rac activation to the leading edge during cell migration (40). The
potential importance of this pathway is underscored our obser-
vations that PKA-mediated phosphorylation of the 4 integrin
subunit, which controls 4–paxillin interaction (41), is not only
enriched in Pd during smooth muscle cell migration (42) but is
also blocked by disruption of PKA anchoring (Fig. 9, which is
published as supporting information on the PNAS web site).
Although it is clear that regulation of Rac represents a
pathway of major importance for localized PKA activity during
cell migration, the growing list of relevant substrates for PTP-
PEST (see refs. 22 and 31) provides several other potential
targets. Indeed, the complexity of cytoskeletal regulation and
chemotaxis (1, 43) and the promiscuity of PKA as a kinase (5)
make identification of a single, key target for PKA in chemotaxis
unlikely. Even within the scope of the current study, several
targets have been identified. It is most likely that localization of
PKA activity during migration affects many targets, with the
relevance of each depending on how important and how unique
its contribution is to a given cell’s migration. Clearly, more
experimentation is needed to fully elucidate the mechanism of
localization, identify additional relevant targets, and define
cell-type specificities for the localization of PKA during cell
migration. The ability of AKAPs to serve not only as location-
specific anchors but as scaffolds for multiple signaling enzymes
(20) portends an even greater level of spatial regulation and
functional heterogeneity for PKA. The current data provide a
foundation in this regard by demonstrating that it is not simply
a matter of PKA signaling exerting a blanket negative or positive
effect on the cytoskeleton or cell migration. Rather, it appears
to be a balance of PKA activity, in extent, time, and subcellular
space, that is crucial for successful cell movement.
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